RenovoRx Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx’s patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy’s toxicities versus systemic intravenous therapy.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy RenovoRx Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for RenovoRx Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for RenovoRx Inc. is RNXT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
RenovoRx Inc. has its primary listing on NASDAQ (Small cap). You can trade RenovoRx Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, RenovoRx Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include RenovoRx Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like RenovoRx Inc..